Business / Finance

RSS

FUJIFILM commences tender offer for outstanding shares of SonoSite

FUJIFILM Holdings Corporation, a diversified technology company that operates in healthcare, highly functional materials, and document solutions, announced today the commencement of a tender offer through its indirect wholly-owned U.S. subsidiary Salmon Acquisition Corporation for all outstanding shares of common stock of SonoSite, Inc. for $54 per share, net to the seller in cash, without interest and less any required withholding taxes.

17 Jan 2012

Mentor executes long-term funding agreement to receive 50% ownership in Brighter Day Health

Mentor Capital, Inc. announced that it has executed a long-term funding agreement to receive a current 50% ownership in Brighter Day Health, LLC, pending their expected shareholder approval.

17 Jan 2012

Newtricious secures backing of a consortium of investors

Life Sciences company Newtricious has secured the backing of a consortium of investors who will help it to continue to develop its first products focusing on the maintenance of health in people at risk for chronic diseases such as macular degeneration and cardiovascular illnesses.

17 Jan 2012

Rainbow Coral joins forces with BioHouston

Rainbow Coral Corp. positioned itself at the cutting edge of biotechnology innovation today by joining forces with BioHouston, Inc., one of the nation's preeminent drivers of life sciences research and commercialization.

13 Jan 2012

CrystalGenomics raises KRW 3 billion in private placement

CrystalGenomics, Inc., a clinical stage biopharmaceutical company headquartered in Korea, has just announced that it has successfully raised KRW 3 Billion (USD 2.6 Million) in a private placement to the Korea Seoul Life Science Fund.

13 Jan 2012

GC-Rise presents at J.P. Morgan's 30th annual Healthcare Conference

GC-Rise Pharmaceutical Co. Ltd, in which European healthcare venture capital firm INVENTAGES holds a majority stake, has debuted at J.P. Morgan's 30th annual Healthcare Conference in the United States.

13 Jan 2012

U.S. HealthWorks announces acquisition of Priority Medical Care

U.S. HealthWorks, a leading operator of occupational healthcare centers nationwide, today announced the acquisition of Priority Medical Care, operator of two medical clinics in Bridgewater and Somerset.

12 Jan 2012

Merger Sub II completes tender offer for outstanding shares of Pharmasset common stock

Gilead Sciences, Inc. today announced the successful completion of the tender offer by its wholly-owned subsidiary, Royal Merger Sub II Inc., for all of the outstanding shares of common stock of Pharmasset, Inc. a price of $137 per share, net to the seller in cash.

12 Jan 2012

Arena agrees to sell 9,953,250 shares of common stock

Arena Pharmaceuticals, Inc. announced today that it has agreed to sell 9,953,250 shares of its common stock, at a price of $1.65775 per share, and approximately 9,953 shares of its Series D Convertible Preferred Stock, at a price of $1,657.75 per share, in a registered direct public offering to entities affiliated with Deerfield Management, a healthcare investment organization.

11 Jan 2012

Telormedix raises 7.5 million CHF

Telormedix, a clinical stage biopharmaceutical company focused on TLR7 agonists in the treatment of cancer and inflammatory diseases, today announced that it has raised 7.5 Million CHF from existing investors Aravis Venture and Proquest Investments.

10 Jan 2012

Cardio3BioSciences raises €3.1M in non-dilutive funding

The Belgian biotechnology company, Cardio3BioSciences, a leader in the discovery and development of regenerative and protective therapies for the treatment of cardiovascular diseases, today announces it has secured a total of €3.1 million in non-dilutive funding from the Walloon Region and the European Commission's Seventh Framework Programme.

10 Jan 2012

Biomet second quarter net sales increase 4% to $725.1 million

Biomet, Inc. announced today financial results for its second fiscal quarter ended November 30, 2011.

10 Jan 2012

Amylin outlines key strategic priorities for 2012

Amylin Pharmaceuticals, Inc. today outlined its key strategic priorities for 2012, with a strong focus on driving the global commercial value of its diabetes franchise.

10 Jan 2012

ManTech International acquires Evolvent Technologies

ManTech International Corporation today completed the acquisition of Evolvent Technologies, Inc. of Herndon, Va., a focused healthcare-systems integrator with particular strength in federal healthcare systems.

9 Jan 2012

For physicians, the practice of medicine can pose business challenges

CNN reports that physicians sometimes have trouble owning a small business and the Miami Herald reports on how new technology might prove healthful.

9 Jan 2012

Perrigo signs definitive agreement to acquire assets of CanAm Care

Perrigo Company today announced that it has signed a definitive agreement to acquire substantially all of the assets of CanAm Care, a privately-held, Alpharetta, Georgia-based distributor of diabetes care products for approximately $36 million in cash.

9 Jan 2012

HDC, NeoGenomics sign worldwide licensing agreement to develop LDT

Health Discovery Corporation, a molecular diagnostics leader in the use of patent protected advanced mathematical techniques for personalized medicine, has entered into an exclusive worldwide licensing agreement with NeoGenomics, Inc. for laboratory developed tests in the Field of hematopoietic and solid tumor cancers excluding breast cancer, which was previously licensed to Quest Diagnostics and Smart Personalized Medicine and excluding cancer of the retina which was previously committed to Retinalyze, LLC.

9 Jan 2012

Progress report on commercialization of BENLYSTA to be announced at JPMorgan Healthcare Conference

Human Genome Sciences, Inc. will today announce its priority goals for 2012 and report on progress with the commercialization of BENLYSTA (belimumab), the first approved drug for systemic lupus in 56 years, during a presentation this afternoon by H. Thomas Watkins, President and Chief Executive Officer, to financial analysts and investors at the 30th Annual JPMorgan Healthcare Conference in San Francisco.

9 Jan 2012

Pacira provides updated timing for commercial launch of EXPAREL

Pacira Pharmaceuticals, Inc. today provided updated timing for its commercial launch of EXPAREL (bupivacaine liposome injectable suspension), a non-opioid analgesic that was approved by the U.S. Food and Drug Administration (FDA) for administration into the surgical site to produce postsurgical analgesia.

9 Jan 2012

Houston bursts with customers for n3D's Bio-Assembler system

Houston, Texas, the home base of Rainbow Coral Corp.'s biosciences division, is bursting with potential customers for n3D's Bio-Assembler system. Just last month, the largest stem cell lab and bank in North America opened in Sugar Land, the city's fastest-growing suburb.

9 Jan 2012